2022
DOI: 10.1016/j.rmed.2022.106825
|View full text |Cite
|
Sign up to set email alerts
|

Survival in COPD patients treated with bronchoscopic lung volume reduction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
19
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 28 publications
(20 citation statements)
references
References 21 publications
1
19
0
Order By: Relevance
“…COPD is a disease that can be prevented and treated with the characteristics of airflow restriction [ 10 ]. Airflow restriction is not completely reversible and develops continuously, which is related to the abnormal inflammatory response of the lungs to harmful gases or particles such as cigarettes and smoke [ 11 ].…”
Section: Introductionmentioning
confidence: 99%
“…COPD is a disease that can be prevented and treated with the characteristics of airflow restriction [ 10 ]. Airflow restriction is not completely reversible and develops continuously, which is related to the abnormal inflammatory response of the lungs to harmful gases or particles such as cigarettes and smoke [ 11 ].…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, survival rate at 3-year follow-up was quite high (82%). Previously, we [ 29 ] as well as G arner et al . [ 30 ] found that bronchoscopically reducing lung volume in patients with severe hyperinflation can lead to a survival benefit as well, which can also be an important indicator of long-term treatment efficacy.…”
Section: Discussionmentioning
confidence: 77%
“…More recently, in a study of 1,471 patients, the median survival of patients who underwent treatment with BLVR was found to be longer (1.7 years) compared with those who did not receive the treatment, suggesting that BLVR in patients with severe hyperinflation may also lead to a survival benefit. Notably, BLVR in this study was performed using both valves and coils and was found to be an independent predictor of survival after adjusting for other survival-influencing factors such as age, gender, or severity of disease (10).…”
Section: Review Articlementioning
confidence: 77%